Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parkinson Disease 2”

357 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 357 results

Not applicableWithdrawnNCT05497817
What this trial is testing

Evaluate Caregiver Connections Via Technology for Patients With Alzheimer's and Other Types of Dementia

Who this might be right for
Caregiver StressDementiaAlzheimer Dementia+3 more
Mayo Clinic
Early research (Phase 1)UnknownNCT04553978
What this trial is testing

A Single Oral Dose, Crossover Comparative PK Study of WD-1603 in Healthy Subjects Under Fasting Conditions

Who this might be right for
Parkinson Disease
Hong Kong WD Pharmaceutical Co., Limited 8
Early research (Phase 1)Study completedNCT04265027
What this trial is testing

Bioavailability and Bioequivalence Between Two Active Pharmaceutical Ingredient (API) Sources of Opicapone (OPC)

Who this might be right for
Parkinson Disease
Bial - Portela C S.A. 72
Large-scale testing (Phase 3)Study completedNCT02819518
What this trial is testing

Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)

Who this might be right for
Triple Negative Breast Cancer (TNBC)
Merck Sharp & Dohme LLC 882
Not applicableActive Not RecruitingNCT05779839
What this trial is testing

Caregiver Connections Via Technology in Dementia

Who this might be right for
Caregiver StressDementiaAlzheimer Disease+3 more
Mayo Clinic 355
Testing effectiveness (Phase 2)Study completedNCT02577523
What this trial is testing

A Clinical Study of Efficacy, Safety, Tolerability and PK of ND0612H in Subjects With Advanced Parkinson's Disease

Who this might be right for
Parkinson's Disease
NeuroDerm Ltd. 38
Testing effectiveness (Phase 2)Study completedNCT03037203
What this trial is testing

A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness

Who this might be right for
Excessive SleepinessParkinson Disease
Jazz Pharmaceuticals 66
Not applicableStudy completedNCT02552836
What this trial is testing

Efficacy of Psychotherapy for Depressed Parkinson's Disease Patients

Who this might be right for
DepressionParkinson's Disease
Hopital Montfort 63
Testing effectiveness (Phase 2)Study completedNCT02640729
What this trial is testing

Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects With Lewy Body Dementia

Who this might be right for
Lewy Body DementiaVisual Hallucinations
Axovant Sciences Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT00406029
What this trial is testing

Dyskinesia in Parkinson's Disease (Study P04501)

Who this might be right for
Parkinson DiseaseMovement DisordersCentral Nervous System Diseases+2 more
Merck Sharp & Dohme LLC 253
Testing effectiveness (Phase 2)Looking for participantsNCT07252739
What this trial is testing

KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)

Who this might be right for
Malignant Neoplasm
Merck Sharp & Dohme LLC 130
Large-scale testing (Phase 3)Study completedNCT01905657
What this trial is testing

Study of Two Doses of Pembrolizumab (MK-3475) Versus Docetaxel in Previously Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)
Merck Sharp & Dohme LLC 1,034
Testing effectiveness (Phase 2)Study completedNCT02834507
What this trial is testing

Effect of Two Multiple-dose Regimens of BIA 3-202 on the Pharmacokinetics and Motor Response of Levodopa, and on the Erythrocyte Comt Activity in Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease (PD)
Bial - Portela C S.A. 19
Large-scale testing (Phase 3)Study completedNCT00243971
What this trial is testing

A Trial to Compare the Efficacy of Rotigotine Transdermal Patch to That of Ropinirole on Early Morning Motor Impairment and Sleep Disorders in Subjects With Early-Stage, Idiopathic Parkinson's Disease

Who this might be right for
Parkinson's Disease
UCB Pharma
Testing effectiveness (Phase 2)Looking for participantsNCT05319730
What this trial is testing

Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Merck Sharp & Dohme LLC 230
Early research (Phase 1)Study completedNCT02964013
What this trial is testing

Study of Vibostolimab Alone and in Combination With Pembrolizumab in Advanced Solid Tumors (MK-7684-001) ( KEYVIBE-001)

Who this might be right for
Neoplasms
Merck Sharp & Dohme LLC 474
Not applicableNot Yet RecruitingNCT07641569
What this trial is testing

Comparison of Two Different Dual-Task Training Methods in Patients With Parkinson's Disease

Who this might be right for
Parkinson's Disease (PD)
Saglik Bilimleri Universitesi 39
Testing effectiveness (Phase 2)Active Not RecruitingNCT05670782
What this trial is testing

Evaluate Safety and Efficacy of KM-819 in Healthy Adults and Participants with Parkinson's Disease

Who this might be right for
Parkinson Disease
FAScinate Therapeutics Inc. 314
Large-scale testing (Phase 3)Study completedNCT03976323
What this trial is testing

Study of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line (1L) Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC) (MK-7339-006, KEYLYNK-006)

Who this might be right for
Carcinoma, Nonsquamous Non-small-cell Lung
Merck Sharp & Dohme LLC 1,003
Post-approval studies (Phase 4)Study completedNCT00144300
What this trial is testing

Ophthalmologic Safety Study of Pramipexole Immediate Release (IR) Versus Ropinirole in Early Parkinson's Disease (PD) Patients

Who this might be right for
Parkinson Disease
Boehringer Ingelheim 246
Load More Results